Celyad Oncology S.A.
CYAD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$8 | -$41 | -$27 |
| Dep. & Amort. | – | $1 | $1 | $2 |
| Deferred Tax | – | $0 | $0 | -$1 |
| Stock-Based Comp. | – | $1 | $2 | $2 |
| Change in WC | – | -$1 | -$4 | $1 |
| Other Non-Cash | – | -$7 | $14 | -$5 |
| Operating Cash Flow | – | -$15 | -$28 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$1 | -$0 | -$0 |
| Net Acquisitions | – | $0 | $6 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $1 | $0 |
| Other Inv. Act. | – | $1 | $0 | $0 |
| Investing Cash Flow | – | $0 | $7 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$0 | -$1 | -$1 |
| Stock Issued | – | $9 | $0 | $37 |
| Stock Repurch. | – | $0 | -$0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $10 | $4 | $41 |
| Financing Cash Flow | – | $9 | $3 | $40 |
| Forex Effect | – | -$0 | -$0 | $0 |
| Net Chg. in Cash | – | -$5 | -$18 | $13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $12 | $30 | $17 |
| End Cash | – | $7 | $12 | $30 |
| Free Cash Flow | – | -$16 | -$28 | -$27 |